Adherence to inhaled corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma

Conclusion
ICS nonadherence is common in severe eosinophilic asthma patients receiving mepolizumab, and is associated with a lesser reduction in OCS requirements and AER.

Source: European Respiratory Journal - May 6, 2020 Category: Respiratory Medicine Authors: d'Ancona, G., Kavanagh, J., Roxas, C., Green, L., Fernandes, M., Thomson, L., Dhariwal, J., Nanzer, A. M., Jackson, D. J., Kent, B. D. Tags: Asthma and allergy Original Articles: Asthma Source Type: research